APA (7th ed.) Citation

Lei, Y., Liang, X., Zhu, H., Wang, J., Zhang, X., Zhang, X., . . . Liang, W. Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: A systematic review and meta-analysis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Lei, Yongfa, Xiaotian Liang, Hua Zhu, Jin Wang, Xiaochen Zhang, Xiaochen Zhang, Siliang Duan, Siliang Duan, and Weiming Liang. Efficacy and Safety of Lenvatinib Plus Transarterial Chemoembolization with or Without Programmed Death-1 Inhibitors in the Treatment of Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Frontiers Media S.A.

MLA (9th ed.) Citation

Lei, Yongfa, et al. Efficacy and Safety of Lenvatinib Plus Transarterial Chemoembolization with or Without Programmed Death-1 Inhibitors in the Treatment of Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Frontiers Media S.A.